Voloridge Investment Management’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-235,383
Closed -$27.5M 1163
2025
Q1
$27.5M Buy
+235,383
New +$26.8M 0.1% 269
2023
Q1
Sell
-53,680
Closed -$4.14M 1361
2022
Q4
$4.14M Sell
53,680
-160,113
-75% -$9.57M 0.02% 712
2022
Q3
$9.54M Buy
213,793
+101,384
+90% +$5.07M 0.05% 457
2022
Q2
$4.3M Sell
112,409
-102,810
-48% -$3.25M 0.02% 731
2022
Q1
$8.91M Buy
215,219
+28,894
+16% +$896K 0.05% 444
2021
Q4
$7.04M Sell
186,325
-91,315
-33% -$3.36M 0.04% 581
2021
Q3
$9.15M Buy
+277,640
New +$10.8M 0.06% 461
2021
Q2
Sell
-13,020
Closed -$737K 1603
2021
Q1
$737K Buy
+13,020
New +$916K 0.01% 1104
2020
Q2
Sell
-7,285
Closed -$429K 1250
2020
Q1
$429K Buy
+7,285
New +$594K 0.01% 758

Other funds holding AXSM